SG10201702537RA - Mammalian cell culture - Google Patents
Mammalian cell cultureInfo
- Publication number
- SG10201702537RA SG10201702537RA SG10201702537RA SG10201702537RA SG10201702537RA SG 10201702537R A SG10201702537R A SG 10201702537RA SG 10201702537R A SG10201702537R A SG 10201702537RA SG 10201702537R A SG10201702537R A SG 10201702537RA SG 10201702537R A SG10201702537R A SG 10201702537RA
- Authority
- SG
- Singapore
- Prior art keywords
- cell culture
- mammalian cell
- mammalian
- culture
- cell
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title 1
- 210000004962 mammalian cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/99—Serum-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Analytical Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161503737P | 2011-07-01 | 2011-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201702537RA true SG10201702537RA (en) | 2017-04-27 |
Family
ID=46579326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201702537RA SG10201702537RA (en) | 2011-07-01 | 2012-06-29 | Mammalian cell culture |
Country Status (24)
Country | Link |
---|---|
US (7) | US11292829B2 (de) |
EP (2) | EP2837680B1 (de) |
JP (1) | JP5897708B2 (de) |
KR (7) | KR20230114317A (de) |
CN (2) | CN107988166B (de) |
AU (5) | AU2012279230B2 (de) |
BR (2) | BR112013033730B1 (de) |
CA (2) | CA2952347A1 (de) |
CL (2) | CL2013003792A1 (de) |
CY (2) | CY1118863T1 (de) |
DK (2) | DK2726600T3 (de) |
EA (1) | EA039023B1 (de) |
ES (2) | ES2625045T3 (de) |
HK (2) | HK1197081A1 (de) |
HU (2) | HUE033279T2 (de) |
IL (5) | IL288509B2 (de) |
LT (2) | LT2726600T (de) |
MX (1) | MX351974B (de) |
PL (2) | PL2837680T3 (de) |
PT (2) | PT2726600T (de) |
SG (1) | SG10201702537RA (de) |
SI (2) | SI2726600T1 (de) |
WO (1) | WO2013006479A2 (de) |
ZA (1) | ZA201309372B (de) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101663390B (zh) | 2006-09-13 | 2013-10-23 | Abbvie公司 | 使用非动物源水解产物的分批补料细胞培养方法 |
US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
SG10201702922VA (en) | 2008-10-20 | 2017-06-29 | Abbvie Inc | Isolation and purification of antibodies using protein a affinity chromatography |
CA2738499A1 (en) | 2008-10-20 | 2010-04-29 | Abbott Laboratories | Viral inactivation during purification of antibodies |
EP2702077A2 (de) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Verfahren zur steuerung des galactosylierungsprofil von rekombinant exprimierten proteinen |
EP2837680B1 (de) * | 2011-07-01 | 2020-02-26 | Amgen Inc. | Säugetierzellkultur |
US10485869B2 (en) | 2011-10-18 | 2019-11-26 | Coherus Biosciences, Inc. | Etanercept formulations stabilized with meglumine |
PL2768525T3 (pl) | 2011-10-18 | 2019-10-31 | Coherus Biosciences Inc | Preparaty etanerceptu stabilizowane jonami magnezu |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
WO2013158279A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Protein purification methods to reduce acidic species |
WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
US9505833B2 (en) | 2012-04-20 | 2016-11-29 | Abbvie Inc. | Human antibodies that bind human TNF-alpha and methods of preparing the same |
US9249182B2 (en) | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
SG11201500138VA (en) | 2012-07-09 | 2015-03-30 | Coherus Biosciences Inc | Etanercept formulations exhibiting marked reduction in sub-visible particles |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
EP2890782A1 (de) | 2012-09-02 | 2015-07-08 | AbbVie Inc. | Verfahren zur steuerung einer proteinheterogenität |
AU2013315750B9 (en) | 2012-09-11 | 2018-11-15 | Coherus Biosciences, Inc. | Correctly folded etanercept in high purity and excellent yield |
US20150353542A1 (en) * | 2013-01-14 | 2015-12-10 | Amgen Inc. | Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
TWI625390B (zh) | 2013-03-14 | 2018-06-01 | 安美基公司 | 用於增加重組蛋白質之甘露糖含量之方法 |
WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
US8921526B2 (en) | 2013-03-14 | 2014-12-30 | Abbvie, Inc. | Mutated anti-TNFα antibodies and methods of their use |
SG11201507875RA (en) | 2013-03-26 | 2015-10-29 | Coherus Biosciences Inc | Protein production method |
US9481901B2 (en) | 2013-05-30 | 2016-11-01 | Amgen Inc. | Methods for increasing mannose content of recombinant proteins |
US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
US11390663B2 (en) | 2013-10-11 | 2022-07-19 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
JP6621744B2 (ja) * | 2013-10-31 | 2019-12-18 | アムジエン・インコーポレーテツド | 組換えタンパク質のグリコシル化を調節するためのモネンシンの使用 |
US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
EP3083933A1 (de) | 2013-12-20 | 2016-10-26 | Biogen MA Inc. | Verwendung von perfusionssaatkulturen zur verbesserung der biopharmazeutischen fed-batch-produktionskapazitäten und der produktqualität |
JP6732660B2 (ja) | 2014-01-13 | 2020-07-29 | アムジエン・インコーポレーテツド | 組換えタンパク質の高マンノースグリコフォーム含有量を操作するためのオルニチン代謝の調節 |
EP3099324B1 (de) | 2014-01-30 | 2020-04-01 | Coherus Biosciences, Inc. | Perfusionsmedien |
FI3926051T3 (fi) | 2014-06-04 | 2024-06-18 | Amgen Inc | Menetelmiä nisäkässoluviljelmien keräämiseksi |
TWI743024B (zh) | 2014-06-06 | 2021-10-21 | 美商健臻公司 | 灌注培養方法及其用途 |
TWI776235B (zh) * | 2014-06-09 | 2022-09-01 | 美商健臻公司 | 種子罐培養法(seed train processes)及其用途 |
JP6530171B2 (ja) * | 2014-09-09 | 2019-06-12 | 旭化成メディカル株式会社 | 培養産生物の回収方法 |
LT3227454T (lt) | 2014-12-01 | 2020-07-27 | Amgen Inc. | Glikoproteino glikano sudedamosios dalies kiekio keitimo procedūra |
KR102007930B1 (ko) | 2014-12-31 | 2019-08-06 | 주식회사 엘지화학 | 재조합 당단백질의 글리코실화 조절 방법 |
CN105385731B (zh) * | 2015-12-25 | 2018-10-30 | 上海莱士血液制品股份有限公司 | 一种表达重组八因子的灌注培养方法 |
JP2019500878A (ja) * | 2016-01-06 | 2019-01-17 | オンコバイオロジクス,インコーポレイティド | モノクローナル抗体組成物中の高分子量種、酸性荷電種、及び断片の低減 |
MX2018009341A (es) | 2016-02-03 | 2019-05-15 | Oncobiologics Inc | Formulaciones tamponadas para una mayor estabilidad de anticuerpos. |
IL261411B2 (en) * | 2016-03-02 | 2024-03-01 | Lonza Ag | Improved fermentation process |
KR102604992B1 (ko) * | 2017-03-31 | 2023-11-24 | 베링거 인겔하임 인터내셔날 게엠베하 | 관류 배지 |
CA3054593A1 (en) | 2017-03-31 | 2018-10-04 | Boehringer Ingelheim International Gmbh | Perfusion medium |
WO2019032927A1 (en) | 2017-08-09 | 2019-02-14 | Juno Therapeutics, Inc. | METHODS FOR PRODUCING GENETICALLY MODIFIED CELL COMPOSITIONS AND COMPOSITIONS THEREOF |
US11609120B2 (en) | 2017-10-06 | 2023-03-21 | Lonza Ltd | Automated control of cell culture using Raman spectroscopy |
JP7337784B2 (ja) | 2017-10-16 | 2023-09-04 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 灌流バイオリアクタ及び関連する使用方法 |
JP2021505168A (ja) * | 2017-12-08 | 2021-02-18 | ジュノー セラピューティクス インコーポレイテッド | 操作されたt細胞の組成物を製造するための方法 |
FI3818078T3 (fi) * | 2018-07-03 | 2024-05-14 | Bristol Myers Squibb Co | Menetelmiä rekombinanttiproteiinien tuottamiseksi |
US11680239B2 (en) | 2018-12-31 | 2023-06-20 | Repligen Corporation | Filter for mammalian cell culture perfusion and clarification with hydrophobic hollow fiber |
WO2021058713A1 (en) * | 2019-09-27 | 2021-04-01 | Boehringer Ingelheim International Gmbh | Concentrated perfusion medium |
KR20230042125A (ko) * | 2020-08-14 | 2023-03-27 | 브리스톨-마이어스 스큅 컴퍼니 | 단백질에 대한 제조 공정 |
US20220064591A1 (en) * | 2020-08-31 | 2022-03-03 | Regeneron Pharmaceuticals, Inc. | Asparagine feed strategies to improve cell culture performance and mitigate asparagine sequence variants |
EP4217383A1 (de) | 2020-09-22 | 2023-08-02 | Bristol-Myers Squibb Company | Verfahren zur herstellung therapeutischer proteine |
CN114574430A (zh) * | 2022-03-22 | 2022-06-03 | 成都博宠生物科技有限公司 | 一种Expi293F细胞培养方法 |
CN115287251A (zh) * | 2022-08-25 | 2022-11-04 | 无锡药明生物技术股份有限公司 | 间歇性灌流联合分批流加培养 |
WO2024054414A1 (en) | 2022-09-06 | 2024-03-14 | Amgen Inc. | Lean perfusion cell culture methods |
WO2024059235A2 (en) | 2022-09-16 | 2024-03-21 | Amgen Inc. | A method for harvesting products from perfusion cultures |
CN116790483B (zh) * | 2023-08-22 | 2023-10-20 | 苏州依科赛生物科技股份有限公司 | 一种cho细胞无血清培养基及其应用 |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936694B1 (en) | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
US4499064A (en) | 1982-06-03 | 1985-02-12 | Clayton Foundation For Research | Assessment of nutritional status of individuals |
AU588819B2 (en) | 1984-10-29 | 1989-09-28 | Immunex Corporation | Cloning of human granulocyte-macrophage colony stimulating factor gene |
US5672502A (en) | 1985-06-28 | 1997-09-30 | Celltech Therapeutics Limited | Animal cell culture |
US4816401A (en) * | 1985-09-09 | 1989-03-28 | University Of Rochester | Serum free cell culture medium |
US5045468A (en) * | 1986-12-12 | 1991-09-03 | Cell Enterprises, Inc. | Protein-free culture medium which promotes hybridoma growth |
US4968607A (en) | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
AU643427B2 (en) | 1988-10-31 | 1993-11-18 | Immunex Corporation | Interleukin-4 receptors |
US5143842A (en) * | 1988-11-01 | 1992-09-01 | The University Of Colorado Foundation, Inc. | Media for normal human muscle satellite cells |
US5395760A (en) | 1989-09-05 | 1995-03-07 | Immunex Corporation | DNA encoding tumor necrosis factor-α and -β receptors |
DE59010933D1 (de) | 1989-09-12 | 2003-05-08 | Hoffmann La Roche | TFN-bindende Proteine |
US6204363B1 (en) | 1989-10-16 | 2001-03-20 | Amgen Inc. | Stem cell factor |
US5272064A (en) | 1989-12-19 | 1993-12-21 | Amgen Inc. | DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof |
US5149792A (en) | 1989-12-19 | 1992-09-22 | Amgen Inc. | Platelet-derived growth factor B chain analogs |
US5292655A (en) * | 1990-01-29 | 1994-03-08 | Wille Jr John J | Method for the formation of a histologically-complete skin substitute |
US7037721B1 (en) * | 1990-01-29 | 2006-05-02 | Hy-Gene Biomedical, Inc. | Protein-free defined media for the growth of normal human keratinocytes |
US5350683A (en) | 1990-06-05 | 1994-09-27 | Immunex Corporation | DNA encoding type II interleukin-1 receptors |
WO1991018982A1 (en) | 1990-06-05 | 1991-12-12 | Immunex Corporation | Type ii interleukin-1 receptors |
GB9118664D0 (en) | 1991-08-30 | 1991-10-16 | Celltech Ltd | Cell culture |
ES2198414T3 (es) | 1992-10-23 | 2004-02-01 | Immunex Corporation | Procedimientos para preparar proteinas oligomericas solubles. |
US5554512A (en) | 1993-05-24 | 1996-09-10 | Immunex Corporation | Ligands for flt3 receptors |
US6310185B1 (en) | 1994-03-08 | 2001-10-30 | Memorial Sloan Kettering Cancer Center | Recombinant human anti-Lewis Y antibodies |
US5856179A (en) | 1994-03-10 | 1999-01-05 | Genentech, Inc. | Polypeptide production in animal cell culture |
US5981713A (en) | 1994-10-13 | 1999-11-09 | Applied Research Systems Ars Holding N.V. | Antibodies to intereleukin-1 antagonists |
NZ311982A (en) | 1995-06-29 | 1999-08-30 | Immunex Corp | Tnf related apoptosis inducing ligand (trail), a method for producing them and associated antibodies |
US6613544B1 (en) | 1995-12-22 | 2003-09-02 | Amgen Inc. | Osteoprotegerin |
US6096728A (en) | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
WO1998008934A1 (en) | 1996-08-30 | 1998-03-05 | Life Technologies, Inc. | Serum-free mammalian cell culture medium, and uses thereof |
US6271349B1 (en) | 1996-12-23 | 2001-08-07 | Immunex Corporation | Receptor activator of NF-κB |
US20020012991A1 (en) | 1997-04-07 | 2002-01-31 | Florence Chua Nee Ho Kit Fong | Cell culture media for enhanced protein production |
US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
US6337072B1 (en) | 1998-04-03 | 2002-01-08 | Hyseq, Inc. | Interleukin-1 receptor antagonist and recombinant production thereof |
WO2001036637A1 (en) | 1999-11-17 | 2001-05-25 | Immunex Corporation | Receptor activator of nf-kappa b |
US6544424B1 (en) | 1999-12-03 | 2003-04-08 | Refined Technology Company | Fluid filtration system |
US20030036505A1 (en) | 2000-09-25 | 2003-02-20 | Human Genome Sciences, Inc. | Signal transduction pathway component polynucleotides, polypeptides, antibodies and methods based thereon |
EP1404813A4 (de) | 2001-06-13 | 2004-11-24 | Genentech Inc | Verfahren zur kultivierung tierischer zellen und polypeptidproduktion in tierischen zellen |
US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
JP2005521401A (ja) | 2002-03-27 | 2005-07-21 | イミュネックス・コーポレーション | ポリペプチド産生を増加させる方法 |
KR101050585B1 (ko) * | 2004-03-05 | 2011-07-19 | 디에스엠 아이피 어셋츠 비.브이. | 연속식 살포 및 교호 접선 흐름에 의한 세포 배양 방법 |
CN1332024C (zh) * | 2004-06-09 | 2007-08-15 | 中国科学院大连化学物理研究所 | 一种海绵细胞的微载体三维培养方法 |
EP2156852B1 (de) | 2004-07-07 | 2011-04-13 | Coloplast A/S | Katheter enthaltend ESTANE 58212 |
TWI384069B (zh) | 2004-08-27 | 2013-02-01 | Pfizer Ireland Pharmaceuticals | 多胜肽之製法 |
TWI374935B (en) * | 2004-08-27 | 2012-10-21 | Pfizer Ireland Pharmaceuticals | Production of α-abeta |
AU2005302516A1 (en) * | 2004-10-29 | 2006-05-11 | Centocor, Inc. | Chemically defined media compositions |
DK2267024T3 (da) | 2005-06-03 | 2012-06-25 | Ares Trading Sa | Fremstilling af rekombinant II-18 bindingsprotein |
KR101685246B1 (ko) | 2006-07-14 | 2016-12-09 | 디피엑스 홀딩스 비.브이. | 개선된 세포 배양 방법 |
US20080206819A1 (en) * | 2006-08-21 | 2008-08-28 | Mary Tsao | Intensified Perfusion Production Method |
EP2078071B1 (de) | 2006-11-08 | 2015-03-18 | Wyeth LLC | Rational entworfene medien für zellkultur |
WO2008154014A2 (en) | 2007-06-11 | 2008-12-18 | Amgen Inc. | A method for culturing mammalian cells to improve recombinant protein production |
EP3327132A3 (de) | 2007-08-09 | 2018-07-18 | Wyeth LLC | Verwendung von perfusion zur erhöhung der produktion von fed-batch-zellkulturen in bioreaktoren |
MX347112B (es) | 2008-09-15 | 2017-04-12 | Genentech Inc | Composiciones y metodos para regular osmolaridad celular. |
CN101603026B (zh) * | 2009-06-19 | 2011-01-19 | 华东理工大学 | 适于动物细胞产品生产的无动物来源低蛋白培养基 |
US8580554B2 (en) | 2009-07-31 | 2013-11-12 | Baxter International Inc. | Method of producing a polypeptide or virus of interest in a continuous cell culture |
US8313926B2 (en) | 2009-07-31 | 2012-11-20 | Baxter International Inc. | Methods for expressing ADAMTS proteins in cell culture medium supplemented with zinc |
LT2464725T (lt) | 2009-08-11 | 2020-06-10 | F. Hoffmann-La Roche Ag | Baltymų gamyba ląstelių mitybinėje terpėje, kurioje nėra glutamino |
PT2501822T (pt) | 2009-11-17 | 2017-10-18 | Squibb & Sons Llc | Métodos para produção de proteínas melhorada |
WO2011065940A1 (en) | 2009-11-24 | 2011-06-03 | Biogen Idec Ma Inc. | Method of supplementing culture media to prevent undesirable amino acid substitutions |
US9217039B2 (en) * | 2010-11-01 | 2015-12-22 | Symphogen A/S | Anti-HER3 antibodies and compositions |
WO2012145682A1 (en) * | 2011-04-21 | 2012-10-26 | Amgen Inc. | A method for culturing mammalian cells to improve recombinant protein production |
EP2837680B1 (de) * | 2011-07-01 | 2020-02-26 | Amgen Inc. | Säugetierzellkultur |
TWI625390B (zh) | 2013-03-14 | 2018-06-01 | 安美基公司 | 用於增加重組蛋白質之甘露糖含量之方法 |
JP6621744B2 (ja) | 2013-10-31 | 2019-12-18 | アムジエン・インコーポレーテツド | 組換えタンパク質のグリコシル化を調節するためのモネンシンの使用 |
MX2018006063A (es) * | 2015-11-17 | 2018-09-17 | Pfizer | Medios y metodos de fermentacion para producir polisacarido en cultivo celular bacteriano. |
-
2012
- 2012-06-29 EP EP14187232.5A patent/EP2837680B1/de active Active
- 2012-06-29 CA CA2952347A patent/CA2952347A1/en not_active Abandoned
- 2012-06-29 LT LTEP12738674.6T patent/LT2726600T/lt unknown
- 2012-06-29 US US14/127,050 patent/US11292829B2/en active Active
- 2012-06-29 WO PCT/US2012/045070 patent/WO2013006479A2/en active Application Filing
- 2012-06-29 HU HUE12738674A patent/HUE033279T2/en unknown
- 2012-06-29 DK DK12738674.6T patent/DK2726600T3/en active
- 2012-06-29 AU AU2012279230A patent/AU2012279230B2/en active Active
- 2012-06-29 PT PT127386746T patent/PT2726600T/pt unknown
- 2012-06-29 PT PT141872325T patent/PT2837680T/pt unknown
- 2012-06-29 KR KR1020237024499A patent/KR20230114317A/ko active IP Right Grant
- 2012-06-29 ES ES12738674.6T patent/ES2625045T3/es active Active
- 2012-06-29 EP EP12738674.6A patent/EP2726600B1/de not_active Revoked
- 2012-06-29 IL IL288509A patent/IL288509B2/en unknown
- 2012-06-29 KR KR1020227003428A patent/KR102558247B1/ko active IP Right Grant
- 2012-06-29 JP JP2014519184A patent/JP5897708B2/ja active Active
- 2012-06-29 BR BR112013033730-3A patent/BR112013033730B1/pt active IP Right Grant
- 2012-06-29 KR KR1020167015700A patent/KR101857380B1/ko active IP Right Grant
- 2012-06-29 CA CA2838695A patent/CA2838695C/en not_active Expired - Fee Related
- 2012-06-29 SG SG10201702537RA patent/SG10201702537RA/en unknown
- 2012-06-29 MX MX2013014937A patent/MX351974B/es active IP Right Grant
- 2012-06-29 CN CN201711406697.2A patent/CN107988166B/zh active Active
- 2012-06-29 KR KR1020207012533A patent/KR102358951B1/ko active IP Right Grant
- 2012-06-29 EA EA201391826A patent/EA039023B1/ru unknown
- 2012-06-29 DK DK14187232.5T patent/DK2837680T3/da active
- 2012-06-29 BR BR122021007265-5A patent/BR122021007265B1/pt active IP Right Grant
- 2012-06-29 ES ES14187232T patent/ES2788132T3/es active Active
- 2012-06-29 SI SI201230945A patent/SI2726600T1/sl unknown
- 2012-06-29 PL PL14187232T patent/PL2837680T3/pl unknown
- 2012-06-29 SI SI201231761T patent/SI2837680T1/sl unknown
- 2012-06-29 PL PL12738674T patent/PL2726600T3/pl unknown
- 2012-06-29 KR KR1020237043604A patent/KR20240005106A/ko not_active Application Discontinuation
- 2012-06-29 KR KR1020147001985A patent/KR101662412B1/ko active IP Right Grant
- 2012-06-29 CN CN201280032874.4A patent/CN103827292B/zh active Active
- 2012-06-29 IL IL297998A patent/IL297998B2/en unknown
- 2012-06-29 IL IL310968A patent/IL310968A/en unknown
- 2012-06-29 KR KR1020187012639A patent/KR102108663B1/ko active IP Right Grant
- 2012-06-29 LT LTEP14187232.5T patent/LT2837680T/lt unknown
- 2012-06-29 HU HUE14187232A patent/HUE049119T2/hu unknown
-
2013
- 2013-12-05 IL IL229803A patent/IL229803B/en active IP Right Grant
- 2013-12-10 ZA ZA2013/09372A patent/ZA201309372B/en unknown
- 2013-12-30 CL CL2013003792A patent/CL2013003792A1/es unknown
-
2014
- 2014-10-20 HK HK14110449A patent/HK1197081A1/xx unknown
- 2014-10-20 HK HK15106530.7A patent/HK1206057A1/xx unknown
-
2016
- 2016-05-18 CL CL2016001190A patent/CL2016001190A1/es unknown
- 2016-10-12 AU AU2016244255A patent/AU2016244255A1/en not_active Abandoned
-
2017
- 2017-03-22 CY CY20171100366T patent/CY1118863T1/el unknown
-
2018
- 2018-06-05 AU AU2018203972A patent/AU2018203972B2/en active Active
-
2020
- 2020-05-25 CY CY20201100473T patent/CY1123146T1/el unknown
- 2020-09-11 US US17/018,564 patent/US11673941B2/en active Active
- 2020-09-11 US US17/018,557 patent/US11634476B2/en active Active
- 2020-11-02 IL IL278430A patent/IL278430B/en unknown
- 2020-12-03 AU AU2020281075A patent/AU2020281075B2/en active Active
-
2022
- 2022-03-04 US US17/686,766 patent/US20220185869A1/en active Pending
- 2022-12-14 US US18/066,251 patent/US11685772B2/en active Active
- 2022-12-20 US US18/068,922 patent/US20230129523A1/en active Pending
-
2023
- 2023-02-24 AU AU2023201127A patent/AU2023201127A1/en active Pending
- 2023-03-08 US US18/180,828 patent/US11827692B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288509A (en) | Mammalian cell culture | |
SG10201601434RA (en) | Cell Culture System | |
EP2729561A4 (de) | Zellkulturverfahren | |
EP2759592A4 (de) | Adhäsionszellkulturverfahren | |
HK1183057A1 (en) | Cell culture insert | |
SG11201503579RA (en) | Cell culture med | |
EP2772530A4 (de) | Zellkulturassay | |
EP3144319B8 (de) | Zellkulturzusammensetzung mit laminin-521 | |
SG11201500417PA (en) | Cell culture | |
EP2796537A4 (de) | Zellkulturträger | |
PL2776552T3 (pl) | Urządzenie do hodowli komórek | |
GB201211873D0 (en) | Cell culture | |
GB201114752D0 (en) | Cell staining process | |
GB201007863D0 (en) | Bioreactor for cell culture | |
GB201120446D0 (en) | Mammalian cell transformation method | |
GB201007855D0 (en) | Bioreactor for the culture of cells | |
GB201016327D0 (en) | Mammalian cell preservation methods | |
AU2011903899A0 (en) | Cell culture & expansion | |
GB201000999D0 (en) | Mammalian cell preservation methods | |
PL393251A1 (pl) | Mikroukład do hodowli komórkowej | |
GB201115343D0 (en) | Mammalian Haploid embryonic stem cells | |
GB201110577D0 (en) | Culturing microorganisms | |
GB201020075D0 (en) | Mammalian cell transformation method |